Page 23 - Shimadzu Journal vol.5 Issue1

Topics

Shimadzu Global Innovation Summit 2017
- IMAGINE, INNOVATE & INSPIRE –

Shimadzu Corporation held its first Global Innovation Summit in Institute/National Institute of Health, U.S.)
Kyoto, Japan, July 4th & 5th, 2017. The event brought together over - Professor Hian Kee Lee (National University of Singapore, Singapore)
100 scientists from 16 countries in the fields of analytical chemistry - Professor Erich Leitner (Graz University of Technology, Austria)
and medical diagnostics including 11 Key Opinion Leaders (KOL) who - Associate Professor Michelle McIntosh (Monash University, Australia)
spoke about their application of Shimadzu products to research - Associate Professor Alex J. Rai (Columbia University College of
pressing issues in the areas of human health, food safety and Physicians and Surgeons, U.S.)
environmental conservation. - Professor Kevin A. Schug (University of Texas at Arlington, U.S.)
- Associate Professor Sanjeeva Srivastava (Indian Institute of Technolo-
gy, Mumbai, India)
- Professor Sen Takeda (University of Yamanashi, Japan)
- Dr. Chunhua Zhang (Matsumoto Institute of Life Science, Japan)

Many of the KOL work closely with Shimadzu Innovation Centers and
Application Development & Support Center located across the world
including, China, Germany, Singapore and the United States. These
institutes were founded in response to numerous collaborations and
are staffed by Shimadzu scientists and equipped with Shimadzu
instrumentations. This has enabled Shimadzu to stay in touch on a
daily basis with its partner scientists to push projects forward faster.

Dr. Leitner explains that it is initiatives like these that make his
relationship with Shimadzu unique.
"I have been in the business for over three decades and personal
contacts are really important to me.
Advancements in global health have benefited tremendously from It makes a difference if you know the person. Shimadzu is starting to
innovations in scientific methodologies and instrumentations. For communicate much more. They try to speed up things in recent years."
more than a century, Shimadzu has contributed to these innovations
through the development of state-of-the-art analytical instruments
and technologies that are being used around the global.
As a company whose corporate philosophy is "Contributing to Society
through Science and Technology", Shimadzu realizes that to fulfill its
mandate, it is essential to listen to its users, which is why its inaugural
Global Innovation Summit took place at the company headquarters in
Kyoto.
"We have many good scientists and engineers. However, it is not easy
to develop solutions, so we decided to collaborate with more
researchers," said Shuzo Maruyama, General Manager of the
Analytical and Measuring Instruments Division at Shimadzu Corpora-
tion.
The number and diversity of laboratories in which Shimadzu The KOL talks at the two-day summit focused on biomarkers for cancer
instrumentation can be found has grown significantly as the company and other diseases, imaging modalities for precision surgery, and
has expanded its range of equipment to include mass spectrometry, advanced methods to evaluated food and water quality, among other
imaging, and chromatography, to name a few, for the study of omics important state-of-the-art innovations.
science, the safety and quality of food, production of biofuels, and
many other scientific fields.
However, the summit’s aim was not only to solve scientific problems but
was also to bring together Team Shimadzu executives and independent
The summit invited 11 KOL from leading universities and national scientists from different research interests to encourage new approaches
institutes throughout the world and included (in alphabetical order):
towards their respective scientific problems.
- Professor Yi Chen (Chinese Academy of Sciences, China) "Shimadzu should be commended for creating a forum to bring
- Professor Eiichiro Fukusaki (Osaka University, Japan) together experts in all different fields. I have benefitted tremendously. I
- Dr. Hisataka Kobayashi (National Cancer
know there are at least three KOL and a couple of authors that I will
continue conversation with," said Dr. Rai, who spoke about his research
on the study of exosomes from the body to treat prostate cancer.

23